CERTIFIED MEDICATION ASSISTED TREATMENT (MAT) ADVOCATE (CMA)

Medication Assisted Treatment (MAT) Advocacy

The National Alliance for Medication Assisted Recovery (NAMA-R) holds the view that every individual who believes in Medication Assisted Treatment (MAT) is at least a potential  Certified MAT Advocate (CMA).


We encourage all supporters of MAT, patient and non-patient, to become Certified MAT Advocates so that all energies directed toward the advancement of MAT produce positive results.


You do not have to be a patient to be a MAT advocate.


Twenty-five Years ago when NAMA-R first started, methadone advocacy was a few committed individuals who all knew one another. When on those rare occasions that a new advocate became active she or he was mentored by a more experienced advocate.

A few mistakes were made but the same mistake was seldom made twice. The result of a small tight knit group closely collaborating.

MAT Advocacy is no longer a few committed individuals. Hundreds of people with various degrees of skill and knowledge now call themselves MAT Advocates and hundreds more are interested in becoming a Certified MAT Advocate (CMA) if the training is made available.

NAMA-R is taking the lead to insure that there is a standard for MAT advocates and to maintain the level of professionalism that is expected from a NAMA-R advocate. It is also important that new MAT advocates have the same opportunities of those that came before them. NAMA-R’s wealth resides with our dedicated advocates who are willing to share their experience with others who also want to make a difference.

Therefore, this training course has the potential to make significant changes in MAT by creating a powerful national group of patients and professionals who see themselves as a community that is working towards a common goal. For far to long MAT has been misunderstood and disparaged; it is time for MAT to be recognized as the “Gold Standard” for addiction treatments.


MAT Advocate Certification Committee

Training Coordinator:

Email:

Address:

Walter Ginter, CMA

Training Committee

National Alliance for Medication Assisted Recovery

435 Second Avenue

New York, NY 10010

Similar Posts

  • NAMA Recovery Advocate

    Admin 11/22/2022

    April 2012 CONTENTS NAMA-Recovery Petition Site has Amassed over 3800 Signatures and 1st Person Testimonials Regarding Methadone Treatments Life-Saving Effects. Methadone Treatment Under Pressure in Many Jurisdictions, but Nowhere as Critical as the British Isles. (Conservative Government releases Putting Recovery First — a Roadmap for the Elimination of MAT and Full Implementation of Abstinance Based…

  • LAAM Warning

    Admin 07/05/2021

    FDA Warns About Orlaam T01-15 Print Media: 301-827-6242 April 20, 2001 Broadcast Media: 301-827-3434   Consumer Inquiries: 888-INFO-FDA The U.S. Food and Drug Administration (FDA) issued a new warning about health risks associated with levomethadyl acetate HC, a.k.a. Orlaam, a drug used to treat opiate addiction. FDA Announces Labeling Changes Following Cardiac Adverse Events With…

  • NAMA Policy Statement: Blind Dosing and Patient Dignity

    Admin 06/10/2023

    Methadone maintenance treatment has been the most effective treatment for addiction to heroin resulting the cessation of heroin use and criminal behavior. Prior to the development of methadone maintenance treatment over 28 years ago narcotic addiction was considered incurable and a behavioral disorder under the control of law enforcement. Drs. Dole and Nyswander brought the…

  • Answer one

    Admin 12/31/2022

    FALSE! Current research shows that doses below 60 mg/day are “not effective and hence not appropriate” and that low dose policies for pregnant and non-pregnant patients are associated with increased drug use as well as reduced program retention. Medical withdrawal of opioid dependent women is not recommended in pregnancy because of increased risk to the…